Drugmaker GlaxoSmithKline sales fall by a worse-than-expected 13% in the 2nd...
Drugmaker GlaxoSmithKline sales fall by a worse-than-expected 13% in the 2nd quarter as lung drugs struggle in the US - @ReutersBiz
View ArticleBritish man who carried out internal probe for drugmaker GlaxoSmithKline in...
British man who carried out internal probe for drugmaker GlaxoSmithKline in China jailed for breaking privacy laws - @SkyNews
View ArticleTrial organizers say 1st human volunteer in UK safety trial of experimental...
Trial organizers say 1st human volunteer in UK safety trial of experimental Ebola vaccine to be injected with the shot next week - @Reuters
View ArticlePhoto: Former National Health Service nurse Ruth Atkins became the 1st Briton...
Photo: Former National Health Service nurse Ruth Atkins became the 1st Briton to be tested with a new Ebola vaccine Wednesday - @itvnews
View ArticleState news: Chinese court fines GlaxoSmithKline's China unit $487 million in...
State news: Chinese court fines GlaxoSmithKline's China unit $487 million in bribery and corruption case - @nytimes
View ArticleGlaxoSmithKline reports 3rd-quarter revenue down 3% to £5.6 billion versus...
GlaxoSmithKline reports 3rd-quarter revenue down 3% to £5.6 billion versus forecast of £5.75 billion - @CNBCWorld
View ArticleGlaxoSmithKline expects to have the first doses of its Ebola vaccine ready...
GlaxoSmithKline expects to have the first doses of its Ebola vaccine ready late 2014, is looking to work with the rest of the pharmaceutical industry to scale up production - @Reuters
View ArticleStudy: Glaxo Ebola vaccine caused no serious side effects, produced an immune...
Study: Glaxo Ebola vaccine caused no serious side effects, produced an immune response - @Reuters
View ArticleDrug-maker GlaxoSmithKline is planning a reorganization that will include...
Drug-maker GlaxoSmithKline is planning a reorganization that will include hundreds of job cuts in the US - @BloombergNews
View ArticleGlaxoSmithKline announces 900 layoffs in North Carolina's Research Triangle...
GlaxoSmithKline announces 900 layoffs in North Carolina's Research Triangle area - @ABC11_WTVD
View ArticleGlaxoSmithKline decides not to sell portfolio of older drugs marketed in...
GlaxoSmithKline decides not to sell portfolio of older drugs marketed in North America and Europe after considering offers from potential buyers - @ReutersBiz
View ArticleUS health officials say larger clinical trials of Ebola treatments by...
US health officials say larger clinical trials of Ebola treatments by GlaxosmithKline and NewLink Genetics with Merck to begin in Liberia in next 2 weeks - @Reuters
View Article2 experimental ebola vaccines, from Glaxo and NewLink Genetics, being tested...
2 experimental ebola vaccines, from Glaxo and NewLink Genetics, being tested in Africa appear safe - @Reuters
View ArticleGlaxoSmithKline jumps 3% on better than expected 2nd quarter earnings per...
GlaxoSmithKline jumps 3% on better than expected 2nd quarter earnings per share - @CNBCWorld
View ArticleDrugmaker GlaxoSmithKline closes North Carolina plant over Legionnaire's...
Drugmaker GlaxoSmithKline closes North Carolina plant over Legionnaire's bacteria in cooling tower - @ajam
View ArticleNovartis spending $1 billion to buy experimental Multiple Sclerosis drug from...
Novartis spending $1 billion to buy experimental Multiple Sclerosis drug from Glaxo - @nytimesbusiness
View ArticleGlaxoSmithKline says it has potential to file up to 20 new drugs for approval...
GlaxoSmithKline says it has potential to file up to 20 new drugs for approval before 2020 - @Reuters
View ArticleGlaxoSmithKline posts loss of $616 million for 4th quarter as drugmaker...
GlaxoSmithKline posts loss of $616 million for 4th quarter as drugmaker continues integration and restructuring program - AP
View ArticlePharma giant GlaxoSmithKline says CEO Andrew Witty to retire in 2017 - Reuters
Pharma giant GlaxoSmithKline says CEO Andrew Witty to retire in 2017 - Reuters
View ArticleTop investor in GlaxoSmithKline calls for outside to replace current CEO...
Top investor in GlaxoSmithKline calls for outside to replace current CEO Andrew Witty - Reuters
View Article